Trademark Overview
On Monday, March 16, 2026, a trademark application was filed for CASPIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CASPIAN THERAPEUTICS trademark a serial number of 99705023. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 16, 2026. This trademark is owned by Kura Oncology, Inc.. The CASPIAN THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of diabetes and cardiometabolic, cardiovascular, menin, and metabolic related diseases, disorders, and conditions.
Providing information in the fields of diabetes and cardiometabolic, cardiovascular, menin, and metabolic related diseases, disorders, and conditions; Providing a website featuring information in the fields of diabetes and cardiometabolic, cardiovascular, menin, and metabolic related diseases, disorders, and conditions.
Providing medical and scientific research information in the field of treatment of diabetes and cardiometabolic, cardiovascular, menin, and metabolic related diseases, disorders, and conditions, and clinical trials and post-market trials related to treatment of diabetes and cardiometabolic, cardiovascular, menin, and metabolic related diseases, disorders, and conditions; Consulting services in the field of research and development of treatments of diabetes and cardiometabolic, cardiovascular, menin, and metabolic related diseases, disorders, and conditions; Diabetes and cardiometabolic, cardiovascular, menin, and metabolic related diseases, disorders, and conditions treatment research and development.
